The A.R.R.E.S.T.® Contact Lens Study
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age7-15
Sponsornthalmic Pty Ltd
About this trial
The goal of this clinical trial is to learn if contact lenses using Active Reconfiguration in Retinal Encoding of Spatio-Temporal (A.R.R.E.S.T.®) signal technology works to slow down the rate of myopia progression compared to single vision contact lenses in myopic children. The main questions it aims to answer are:
Do contact lenses using A.R.R.E.S.T.® technology slow down the rate of axial length growth? Do contact lenses using A.R.R.E.S.T.® technology slow down the rate of increase in myopic refractive error?
Researchers will compare contact lenses using A.R.R.E.S.T.® technology to a single vision contact lens.
Participants will:
Be randomly allocated to wear either contact lenses using A.R.R.E.S.T.® technology or single vision contact lenses.
Visit the clinic on seven occasions over a 12 month period.
Eligibility criteria
Qualifiers
Be between 7 to 15 years old inclusive at time of enrolment.
Read the Informed Assent.
Been explained the Informed Assent.
Indicated an understanding of the Informed Assent.
Disqualifiers
Participant in another study within 30 days prior to this study.
Bifocal / multifocal spectacles.
Bifocal / multifocal contact lenses.
Orthokeratology.
Trial design
Treatments tested in this trial
- Single-vision contact lens
- A.R.R.E.S.T.® contact lens
Treatment groups
80 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov